Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy
Cells · 2023
DOI: 10.3390/cells12060851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Lara Heij und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Transplantation, University Hospital RWTH Aachen, 52074 Aachen, Germany. Hauptthemen laut MEDLINE: B7-H1 Antigen, Cholangiocarcinoma. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Background
The tumor microenvironment (TME) in cholangiocarcinoma (CCA) influences the immune environment. Checkpoint blockade is promising, but reliable biomarkers to predict response to treatment are still lacking. Materials and Methods: The levels of checkpoint molecules (PD-1, PD-L1, PD-L2, LAG-3, ICOS, TIGIT, TIM-3, CTLA-4), macrophages (CD68), and T cells (CD4 and CD8 cells) were assessed by multiplexed immunofluorescence in 50 intrahepatic cases. Associations between marker expression, immune cells, and region of expression were studied in the annotated regions of tumor, interface, sclerotic tumor, and tumor-free tissue.
Results
ICCA demonstrated CD4_TIM-3 high densities in the tumor region of interest (ROI) compared to the interface (p = 0.014). CD8_PD-L1 and CD8_ICOS densities were elevated in the sclerotic tumor compared to the interface (p = 0.011 and p = 0.031, respectively). In a multivariate model, high expression of CD8_PD-L2 (p = 0.048) and CD4_ICOS_TIGIT (p = 0.011) was associated with nodal metastases.
Conclusions
High densities of PD-L1 were more abundant in the sclerotic tumor region; this is meaningful for the stratification of immunotherapy. Lymph node metastasis correlates with CD4_ICOS_TIGIT co-expression and CD8_PD-L2 expression, indicating the checkpoint expression profile of patients with a poor prognosis. Also, multiple co-expressions occur, and this potentially suggests a role for combination therapy with different immune checkpoint targets than just PD-1 blockade monotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery and Transplantation, University Hospital RWTH Aachen, 52074 Aachen, Germany.
- Institute of Pathology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
- Department of Pathology, Erasmus Medical Center Rotterdam, 3000 CB Rotterdam, The Netherlands.
- NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, 6211 ER Maastricht, The Netherlands.
- Department of Surgery, Maastricht University Medical Center (MUMC), 6202 AZ Maastricht, The Netherlands.
- GROW-School for Oncology and Reproduction, Maastricht University, 6211 ER Maastricht, The Netherlands.
ORCID-Profile: Lara Heij, Jan Bednarsch, Michail Doukas
Förderung
- China Scholarship Council
Zitieren
APA
Heij, L., Bednarsch, J., Tan, X., Rosin, M., Appinger, S., Reichel, K., Pecina, D., Doukas, M., van Dam, R. M., Garcia Vallejo, J., Ulmer, F., Lang, S., Luedde, T., Rocha, F. G., Sivakumar, S., & Neumann, U. P. (2023). Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy. Cells. https://doi.org/10.3390/cells12060851
Vancouver
Heij L, Bednarsch J, Tan X, Rosin M, Appinger S, Reichel K, et al. Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy. Cells. 2023. doi:10.3390/cells12060851
BibTeX
@article{Heij2023,
author = {Heij, Lara and Bednarsch, Jan and Tan, Xiuxiang and Rosin, Mika and Appinger, Simone and Reichel, Konrad and Pecina, Dana and Doukas, Michail and van Dam, Ronald M and Garcia Vallejo, Juan and Ulmer, Florian and Lang, Sven and Luedde, Tom and Rocha, Flavio G and Sivakumar, Shivan and Neumann, Ulf Peter},
title = {Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma: Implications for Immune Checkpoint Blockade Therapy},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12060851}
}
EUVIMED